Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells.

Xiong, Qingqing; Cui, Mangmang; Yu, Ge; Wang, Jian; Song, Tianqiang

Xiong, Qingqing; Cui, Mangmang; Yu, Ge; Wang, Jian; Song, Tianqiang.

Afiliação

Xiong Q; Department of Hepatobiliary Cancer, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Cui M; Department of Hepatobiliary Cancer, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yu G; Hebei province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China.
Wang J; Department of Hepatobiliary Cancer, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Song T; Department of Immunology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Front Pharmacol ; 9: 61, 2018.

Article em En | MEDLINE | ID: mdl-29487523

Palavras-chave

doxorubicin; hepatocellular carcinoma; reduction-responsive; sorafenib; supramolecular nanoassemblies

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google